{
    "nctId": "NCT05800834",
    "briefTitle": "Benefits of Morphine Gel for Pain Reduction in Patients With Cancer Wounds",
    "officialTitle": "Effectiveness of Topical Morphine Use in Patients With Painful Neoplastic Wounds in the Breast and Head and Neck: Double Blind Randomized Clinical Trial - MorphineGEL",
    "overallStatus": "RECRUITING",
    "conditions": "Wounds and Injuries, Cancer Pain, Cancer, Breast, Cancer Head Neck",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE2",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 106,
    "primaryOutcomeMeasure": "Numeric pain rating scale",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Malignant neoplastic wound in breast or head and neck;\n* Malignant neoplastic wound with staging \\>= II;\n* KPS \\>=30%\n* Having at least 3 on the numerical pain rating scale (0-10);\n* Admission time equal to or greater than 48 hours.\n* Make use of systemic morphine.\n\nExclusion Criteria:\n\n* Wound with fistula;\n* Wound with extensive coagulation necrosis (\\>50% of wound area;\n* Exuding wound \\> 1 (PUSH Scale);\n* Bleeding wound \\>1 (VIBe Scale)\n* Ongoing radiotherapy on the wound.",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}